ScreenerHero

SXTC China SXT Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · sxtchina.com
2.830USD+126.40%Mkt Cap: 3.74M $P/E: —

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap3.74M USD
Enterprise Value-26.70M USD
Revenue (TTM)1.14M USD
Gross Profit248.70K USD
Net Income (TTM)-6.21M USD
Revenue/Share1.67 USD
Last Price2.830 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees56
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA3.79
EV/Revenue-23.46
P/S1.45
P/B0.00
EPS (TTM)-730.40
EPS (Forward)—
52W Range
1.1800% of range83760.00
52W High83760.00 USD
52W Low1.180 USD
Profitability
Gross Margin21.85%
Oper. Margin-153.28%
EBITDA Margin0.00%
Profit Margin-545.24%
ROE-20.89%
ROA-17.85%
Growth
Revenue Growth-43.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.02M USD
CapEx (TTM)1.25M USD
FCF Margin-416.16%
FCF Yield-126.65%
Net Debt-27.20M USD
Net Debt/EBITDA3.86
Balance Sheet
Debt/Equity0.04
Current Ratio7.93
Quick Ratio7.23
Book Value/Sh2480.58 USD
Cash/Share70.32 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:80
Split DateAug 10, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.32M
Float401.68K
Insiders33.37%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Float4.96%
Short % Out.4.96%
Shares Short65.51K
Short (prev mo.)26.46K
Technical
SMA 503.442 (-17.8%)
SMA 2001610.42 (-99.8%)
Beta1.86
S&P 52W Chg15.78%
Avg Vol (30d)6.25M
Avg Vol (10d)331.36K
Technical Indicators
RSI (14)45.1
MACD-82.1032
MACD Signal-116.3034
MACD Hist.+34.2002
BB Upper3.216 USD
BB Middle2.425 USD
BB Lower1.633 USD
BB Width65.25%
ATR (14)83.43 USD
Vol Ratio (20d)114.60x